Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001437749-17-008960
Filing Date
2017-05-12
Accepted
2017-05-12 16:56:35
Documents
5
Effectiveness Date
2017-05-12

Document Format Files

Seq Description Document Type Size
1 FORM S-8 atrn20170512_s8.htm S-8 76998
2 EXHIBIT 5.1 ex5-1.htm EX-5.1 1342
3 EXHIBIT 23.1 ex23-1.htm EX-23.1 3447
4 letter2.jpg GRAPHIC 147555
5 letter1.jpg GRAPHIC 202052
  Complete submission text file 0001437749-17-008960.txt   564536
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-217963 | Film No.: 17839550
SIC: 7389 Services-Business Services, NEC